503A vs 503B Pharmacy: The Difference, Explained (2026)
Two kinds of compounding, two sets of rules. Here's who each one serves, and which fills a prescribed peptide for you.
A 503A pharmacy compounds a medicine for one patient, made to order from a valid prescription. A 503B outsourcing facility makes larger batches under stricter FDA manufacturing rules, mostly so clinics can keep stock on hand. Neither one makes an FDA-approved drug when it compounds, and that's normal. For a prescribed peptide filled for you as an individual, a 503A pharmacy is the standard path. pru works with licensed physicians and FDA-regulated 503A pharmacies.
503A vs 503B: the one-line difference
A 503A pharmacy compounds a medicine for one named patient from a specific prescription. A 503B outsourcing facility manufactures larger batches under FDA current good manufacturing practice (cGMP) rules, usually so clinics and hospitals can keep stock on hand for office use.
Both are legitimate. Both are types of compounding. The split comes down to scale and who the medicine is for: one patient at a time (503A) versus batches for provider offices (503B). When you get a prescribed peptide filled for yourself, that is 503A work. Learn more about what a 503A pharmacy is.
The short version503A = made for you, one prescription at a time. 503B = made in batches for clinics to stock. pru's prescribed peptides are filled by FDA-regulated 503A pharmacies.
503A vs 503B pharmacy, side by side
Here is the core difference between 503A and 503B in one view. The rules come from Section 503A and Section 503B of the federal Food, Drug, and Cosmetic Act.
| Feature | 503A pharmacy | 503B outsourcing facility |
|---|---|---|
| Who it's for | One named patient | Clinics, hospitals, and provider offices (stock) |
| Prescription | A patient-specific prescription is required | Batches allowed with or without a patient prescription |
| How much is made | Small, made-to-order amounts | Large manufactured batches |
| Main regulator | State boards of pharmacy, plus FDA | FDA (registered outsourcing facility) |
| Manufacturing standard | Exempt from federal cGMP | Must follow cGMP |
| FDA registration | Not registered as an outsourcing facility | Registers with FDA and agrees to FDA inspections |
| Typical use | Your personalized prescription, filled for home use | Office-use stock for a provider to administer |
What is a 503A pharmacy?
A 503A pharmacy is a state-licensed pharmacy (or a licensed physician) that compounds a medicine for an individual patient based on a valid prescription. It is not registered with the FDA as an outsourcing facility.
503A pharmacies are regulated primarily by state boards of pharmacy, and they must still follow federal law under Section 503A. They compound made-to-order amounts, not large factory batches. A compounded medicine is a legally prescribed medicine that is not itself an FDA-approved product, which is normal for compounding. Here's why compounded peptides aren't FDA-approved.
- Compounds for one patient, from that patient's prescription
- State-regulated, and bound by federal Section 503A rules
- Makes small, made-to-order quantities rather than mass batches
- Fills prescribed compounded peptides for the individual who was prescribed them
What is a 503B outsourcing facility?
A 503B is an outsourcing facility that registers with the FDA and can compound larger batches, with or without a patient-specific prescription, mostly so provider offices, clinics, and hospitals can keep medicine in stock.
Because 503B facilities make batches at scale, federal law holds them to current good manufacturing practice (cGMP), the same broad standard used across pharmaceutical manufacturing. They register with the FDA each year and agree to FDA inspections. A 503B is not a place a single patient usually orders from directly; it supplies the offices that treat patients.
Why cGMP matters herecGMP is a manufacturing standard, not an approval. A 503B following cGMP is not the same as an FDA-approved drug, and a 503A being exempt from cGMP does not mean a 503A is unsafe. They are simply two different lanes with different rules.
Which one fills a compounded peptide prescription?
For a compounded peptide prescribed to you as an individual, a 503A pharmacy is the standard path. You get a prescription from a licensed physician, and a 503A pharmacy compounds that specific prescription for you.
503B outsourcing facilities focus on batch supply for clinics, so they are less common for a personal, at-home peptide prescription. The lane that fits a made-to-order, patient-specific peptide is 503A. What matters most for safety is that a real prescriber and a real licensed pharmacy stand behind the vial, not the specific number in the rule. See how research-grade compares with pharmacy-grade.
Where peptides sit with the FDA in 2026
Compounded peptides are not FDA-approved, and that is expected for compounded medicines. The rules around which peptides a 503A pharmacy may compound are actively moving in 2026, so it helps to know the exact status.
On April 15, 2026, the FDA removed 12 peptides from its 503A Category 2 list, the group of substances the agency had flagged as raising significant safety concerns for compounding. The FDA's Pharmacy Compounding Advisory Committee (PCAC) is set to review 7 of them on July 23-24, 2026: BPC-157, TB-500, KPV, MOTS-C, DSIP, Semax, and Epitalon.
Read this carefullyRemoval from Category 2 is not approval, and it is not the same as being placed on the authorized 503A bulk substances list. It removes a specific prohibition designation while the review continues. Nothing here means a peptide is now FDA-approved.
For the full picture, see FDA peptide rules for 2026 and the PCAC review, explained.
The real risk isn't 503A vs 503B, it's grey-market vials
Choosing between 503A and 503B is a question of the right lane. The bigger safety line is between the pharmacy path and the grey market.
Vials sold as "research-grade" or labeled "not for human use" sit outside both 503A and 503B. There is no prescriber, no licensed pharmacy, and no verified identity, purity, or sterility. That is the setup that carries real risk, not a prescribed, pharmacy-compounded peptide. SARMs raise a similar flag: they are unapproved and carry documented safety and legal concerns, which is why peptides and SARMs are not the same category.
- No prescriber reviewing whether the medicine fits you
- No licensed pharmacy standing behind how it was made
- No verified purity, sterility, or identity of what's in the vial
- Often labeled 'research use only' to sidestep the rules that protect patients
More on this in are compounded peptides safe.
How to tell a legitimate pharmacy path from the grey market
You don't need to memorize pharmacy law to stay safe. A few checks tell you whether a source runs the legitimate path or the grey-market one.
- A licensed physician reviews you and writes the prescription
- A licensed pharmacy compounds and fills it (503A for a personal prescription)
- Every order can be traced to that prescription and that pharmacy
- A Certificate of Analysis (CoA) documents the batch's identity and purity
- The provider or platform is LegitScript-certified
LegitScript certifies legitimate online pharmacies and telemedicine providers, and card networks and major ad platforms rely on it to verify healthcare merchants. See how LegitScript certification works and how to verify a peptide source.
How pru handles this
pru runs the legitimate path start to finish. A licensed physician reviews you and confirms clinical fit. You choose your peptide, guided by pru's education. An FDA-regulated 503A pharmacy compounds and fills your prescription for you as an individual.
Pricing is a flat membership near $50/month, with peptides billed at cost and itemized, no markup. Every order ships with a Certificate of Analysis so you can see what's in the vial. That's the difference between a prescribed, pharmacy-grade peptide and a grey-market vial. Being proactive about your health should not mean paying a premium or guessing at the rules, and pru exists to make the careful path the accessible one.
Learning the difference between these lanes is already you being proactive about your health, and that instinct is worth trusting. When you're ready, you can browse pru's peptide catalog or read up on individual options like GHK-Cu, sermorelin, and PT-141. New to all of this? Start with how to start peptide therapy.
Language that mattersCompounded peptides are pharmacy-grade, prescribed medicines. They are not FDA-approved, and that is normal for compounding. pru does not make disease, cure, or treatment claims about any peptide.
Related reading
- What is a 503A pharmacy?
- Are compounded peptides safe?
- Research-grade vs pharmacy-grade peptides
- FDA peptide regulations in 2026
- LegitScript certification, explained
- How to verify a peptide source
- Browse the pru peptide catalog
Common questions
Sources & further reading
- https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding
- https://www.fda.gov/drugs/human-drug-compounding/compounding-inspections-and-oversight-frequently-asked-questions
- https://www.fda.gov/files/drugs/published/Prescription-Requirement-Under-Section-503A-of-the-Federal-Food--Drug--and-Cosmetic-Act-Guidance-for-Industry.pdf
- https://www.legitscript.com/certification/healthcare-certification/
- joinpru.com/blog